Bumrungrad International Hospital places great importance on quality and standards assessment, focusing on three key outcome indicators that are internationally recognized standards used by leading hospitals worldwide, namely, in-hospital mortality and morbidity rates, timeliness of care, and patient safety. We continually compare our outcomes against world-class standards as we believe these three indicators are important indicators of overall quality of care, the effectiveness of our multidisciplinary teamwork, and our commitment to delivering the best possible outcomes for our patients.
In-hospital mortality and morbidity rates are below the standards set by the American Society of Anesthesiologist, ACC NCDR 90th Percentile, Singapore Data registry, and GRACE registry. This reflects the effectiveness of our treatment and overall outcomes in caring for our patients. Bumrungrad International Hospital continuously strives to reduce mortality rate and complications that may arise from treatment through efficient multidisciplinary teamwork, modern treatment methods and technologies, as well as close monitoring and follow-up. This results in our hospital's mortality and morbidity rates being better than the standard, including the pre-operative, post-operative, and perioperative mortality rates, as well as maternal and neonatal mortality rates.
- Preoperative and postoperative mortality rate: 0.1% (compared to the international standard of 2.1%)
- Perioperative mortality rate: 0.03% (compared to the international standard of 0.5%)
- In-hospital heart failure mortality rate: 0% (compared to the international standard of 5%)
- Stroke mortality rate: 5.8% (compared to the international standard of 7.4%)
- Acute myocardial infarction mortality rate: 3.6% (compared to the international standard of 7.5%)
- Maternal mortality rate: 0% (compared to the international standard of 8/100,000 live births)
- Neonatal mortality rate: 0% (compared to the international standard of 8/10,000 live births)
Bumrungrad Hospital's timeliness of treatment initiation is high compared to the standards of the NCC, NCDR, and Samsung Medical Center in South Korea. This is because we realize that every minute counts in a patient's life and rapid access to treatment is a crucial factor of survival chances and in reducing disease severity. Bumrungrad emphasizes seamless teamwork, development of systems and processes that allow patients to receive timely care at every stage, from diagnosis to treatment initiation, emergency response time, critical radiology reporting turnaround time as well as other key indicators.
- Door-to-balloon time (time between patient’s arrival and coronary intervention) within 90 minutes: 70%
- Door-to-thrombectomy time (time between patient’s arrival and the procedure to achieve reperfusion) within 90 minutes: (N/A, next challenge)
- Critical radiology reporting turnaround time: 97%
- Breast cancer diagnosis within 3 days: 100%
- Breast cancer treatment within 7 days of diagnosis: 98%
Considering “a safety rate higher than standards” when compared to ACS – QVP, AHRQ, CDC, 50th Percentile of NDNQ, Bumrungrad Hospital focuses on patient safety as a core priority. We have a strict patient safety monitoring and assessment system to prevent and reduce potential risks in treatment. The quality of treatment and effective aftercare are apparent in the statistics including the 30-day hospital readmission rate, the 30-day reoperation rate, the in-hospital venous thromboembolism rate and the nosocomial infection rate.
- Unplanned transfer to a higher level of care: 0.3% (compared to the international standard of 3.7%)
- 30-day hospital readmission: 0.42% (compared to the international standard of 3.4%)
- 30-day revision surgery: 0.35% (compared to the international standard of 2.8%)
- Abdominal and pelvic symptoms due to accidental puncture and laceration: 0.97% (compared to the international standard of 0.99%)
- In-hospital venous thromboembolism: 1.33% (compared to the international standard of 1.16%)
- Urinary tract infections in patients with indwelling urinary catheters: 0.68% (compared to the international standard of 0.74%)
- Ventilator-associated pneumonia: 0.56% (compared to the international standard of 0.40%)
- Central line-associated bloodstream infections (CLABSI): 0.18% (compared to the international standard of 0.72%)
- Surgical site infections (SSI): 0.18% (compared to the international standard of 0.12%)